Cardium Therapeutics, Inc. (CXM) Presents First Quarter 2013 Financial Results and Reports on Recent Developments
5/15/2013 7:35:18 AM
More...
|
Cardium Therapeutics, Inc. (CXM) Announces Generx Publication in Molecular Therapy
5/2/2013 10:54:02 AM
More...
|
Cardium Therapeutics, Inc. (CXM) Announces Excellagen Presentation at the Symposium on Advanced Wound Care Spring 2013 Meeting
4/30/2013 8:39:30 AM
More...
|
Cardium Therapeutics, Inc. (CXM) Announces $4.0 Million Preferred Stock Financing and Reports on Exchange Listing Compliance
4/5/2013 9:39:29 AM
More...
|
Cardium Therapeutics, Inc. (CXM) Presents Year-End 2012 Financial Results and Recent Developments
4/5/2013 6:50:08 AM
More...
|
Cardium Therapeutics, Inc. (CXM) Receives ISO Certification for Excellagen
3/14/2013 7:04:54 AM
More...
|
Cardium Therapeutics, Inc. (CXM)'s to Go Brands® to Launch Expanded VitaRocks® Kids Vitamin Line With New Retail Distribution
3/13/2013 10:08:55 AM
More...
|
Cardium Therapeutics, Inc. (CXM)'s Excellagen® Awarded American Podiatric Medical Association Seal of Approval
2/12/2013 9:21:15 AM
More...
|
Cardium Therapeutics, Inc. (CXM) Announces Presentaton at the 2013 Cell & Gene Therapy Forum
1/29/2013 7:35:14 AM
More...
|
Cardium Therapeutics, Inc. (CXM) Exchange Listing Compliance Plan Accepted by NYSE MKT
1/16/2013 9:35:01 AM
More...
|
|